Clostridium difficile-associated disease and mortality among the elderly critically ill

Critical Care Medicine

Volumn 37, Issue 9, 2009, Pages 2583-2589

  Zilberberg, Marya D ^a,b   Shorr, Andrew F ^c   Micek, Scott T ^d   Doherty, Joshua A ^d   Kollef, Marin H ^d  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b EviMed Research Group LLC   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

^d BARNES JEWISH HOSPITAL   (United States)

Author keywords

Clostridium difficile; Critical illness; Elderly; Mortality; Mortality prediction

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; METRONIDAZOLE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CRITICALLY ILL PATIENT; EPIDEMIC; FEMALE; GERIATRIC PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL RECORD REVIEW; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY ANALYSIS; SEPTIC SHOCK;

EID: 69349092544     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181ab8388     Document Type: Article

References (25)

1. McDonald LC, Killgore GE, Thompson A, et al: An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353:2433-2441. Epub 2005 Dec 1 (Pubitemid 41770164)
2. McDonald LC, Owings M, Jernigan DB: Clostridium difficile infection among patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2007; 12: 409-415
3. Zilberberg MD, Shorr AF, Kollef MH: Increase in adult Clostridium difficile-related hospitalizations and case fatality in the US, 2000-2005. Emerg Infect Dis 2008; 14: 929-931
4. HCUPnet: Healthcare Cost and Utilization Project (HCUP). 2000-2004. Agency for Healthcare Research and Quality, Rockville, MD. Available at http://www.ahrq.gov/ HCUPnet/. Accessed May 24, 2008
5. He W, Sengupta M, Velkoff VA, et al: 65+ in the United States: 2005. Current Population Reports. Washington, DC, U.S. Government Printing Office, 2005, pp 23-209
6. Medicare Provider Analysis and Review (MEDPAR) of Short-Stay Hospitals. Baltimore, MD, Centers for Medicare and Medicaid Services, 2004
7. Safdar N, Maki DG: The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002; 136: 834-844 (Pubitemid 34568654)
8. Zilberberg MD, Shorr AF, Kollef MH: Growth in the incidence of hospitalizations with resistant infections among the elderly in the US, 2000-2006. J Am Geriatr Soc 2008; 56: 2356-2358
9. Kenneally C, Rosini JM, Skrupky LP, et al: Analysis of 30-day mortality for Clostridium difficile-associated disease in the ICU setting. Chest 2007; 132:418-424 (Pubitemid 47282371)
10. Iregui M, Ward S, Sherman G, et al: Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilatorassociated pneumonia. Chest 2002; 122: 262-268 (Pubitemid 34754172)
11. Alvarez-Lerma F, ICU-Acquired Pneumonia Study Group: Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med 1996; 22:387-394
12. Kumar A, Roberts D, Wood KE, et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-1596 (Pubitemid 43810035)
13. Micek ST, Kollef KE, Reichley RM, et al: Health care-associated pneumonia and community- acquired pneumonia: A single-center experience. Antimicrob Agents Chemother 2007; 51:3568-3573
14. Kollef MH, Sherman G, Ward S, et al: Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-474 (Pubitemid 29083057)
15. Schramm GE, Johnson JA, Doherty JA, et al: Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment. Crit Care Med 2006; 34: 2069-2074
16. Ibrahim EH, Sherman G, Ward S, et al: The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-155 (Pubitemid 30485502)
17. Bartlett JG, Gerding DN: Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008; 46(Suppl): S12-S18 (Pubitemid 351323661)
18. Pepin J, Valiquette L, Alary M-E, et al: Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: A changing pattern of disease severity. Can Med Assoc J 2004; 171:466-472
19. Knaus WA, Wagner DP, Draper EA, et al: The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-1636
20. Marra AR, Edmond MB, Wenzel RP, et al: Hospital-acquired Clostridium difficileassociated disease in the intensive care unit setting: Epidemiology, clinical course and outcome. BMC Infect Dis 2007; 7:42
21. Loo VG, Poirier L, Miller MA, et al: A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353:2442-2449 (Pubitemid 41770165)
22. Curns AT, Steiner CA, Sejvar JJ, et al: Hospital charges attributable to a primary diagnosis of infectious diseases in older adults in the United States, 1998 to 2004. J Am Geriatr Soc 2008; 56:969-975
23. Yoshikawa TT: Antimicrobial resistance and aging: Beginning of the end of the antibiotic era? J Am Geriatr Soc 2002; 50: S226-S229
24. Catlin A, Cowan C, Hartman M, et al: National health spending in 2006: A year of change for prescription drugs. Health Aff (Millwood) 2008; 27:14-29
25. Cunningham R, Dial S: Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea? J Hosp Infect 2008; 70:1-6